U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H21F3N4O4S
Molecular Weight 494.487
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Uplarafenib

SMILES

CCCS(=O)(=O)NC1=CC(F)=C(F)C(C(=O)C2=CC3=C(C=C2)N=CC(=N3)N4CCOCC4)=C1F

InChI

InChIKey=HAYBWDINAFTFCJ-UHFFFAOYSA-N
InChI=1S/C22H21F3N4O4S/c1-2-9-34(31,32)28-17-11-14(23)20(24)19(21(17)25)22(30)13-3-4-15-16(10-13)27-18(12-26-15)29-5-7-33-8-6-29/h3-4,10-12,28H,2,5-9H2,1H3

HIDE SMILES / InChI

Molecular Formula C22H21F3N4O4S
Molecular Weight 494.487
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 20:17:31 GMT 2023
Edited
by admin
on Sat Dec 16 20:17:31 GMT 2023
Record UNII
TQU3V7CXC3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Uplarafenib
INN  
Official Name English
1-Propanesulfonamide, N-[2,4,5-trifluoro-3-[[3-(4-morpholinyl)-6-quinoxalinyl]carbonyl]phenyl]-
Systematic Name English
uplarafenib [INN]
Common Name English
N-[2,4,5-Trifluoro-3-[[3-(4-morpholinyl)-6-quinoxalinyl]carbonyl]phenyl]-1-propanesulfonamide
Systematic Name English
Code System Code Type Description
CAS
1425485-87-5
Created by admin on Sat Dec 16 20:17:31 GMT 2023 , Edited by admin on Sat Dec 16 20:17:31 GMT 2023
PRIMARY
INN
12781
Created by admin on Sat Dec 16 20:17:31 GMT 2023 , Edited by admin on Sat Dec 16 20:17:31 GMT 2023
PRIMARY
PUBCHEM
71506198
Created by admin on Sat Dec 16 20:17:31 GMT 2023 , Edited by admin on Sat Dec 16 20:17:31 GMT 2023
PRIMARY
FDA UNII
TQU3V7CXC3
Created by admin on Sat Dec 16 20:17:31 GMT 2023 , Edited by admin on Sat Dec 16 20:17:31 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
antineoplastic